Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3041293	s-aripipr	ug/l (—)	91	150	100.00%	Distribution not available
3041293	s-aridhas	ug/l (—)	66	75	100.00%	Distribution not available
3041293	s-aripi	ug/l (—)	61	74	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Schizophrenia or delusion, excluding more controls

132

+∞

137.14

2.0

0.0

—

Schizophrenia or delusion

132

266.94

129.30

2.0

2.6

—

Schizophrenia, schizotypal and delusional disorders

132

266.93

129.30

2.0

2.6

—

Bipolar affective disorders

36.83

70.61

2.1

2.3

—

Mood [affective] disorders

9.91

56.10

2.0

—

Mood disorders

9.90

55.99

2.0

—

Benzodiazepine use

8.40

50.13

1.9

2.0

—

Depression

8.83

45.55

2.0

—

Substance abuse, excluding more controls

+∞

44.06

2.3

0.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

11.61

42.89

2.2

1.9

—

Personality disorders, excluding more controls

+∞

42.72

1.8

0.0

—

Other anxiety disorders

9.01

41.19

2.1

2.2

—

Disorders of adult personality and behaviour

10.50

40.15

1.9

2.1

—

Poisoning by drugs, medicaments and biological substances

13.25

39.07

2.1

1.8

—

Suicide or other Intentional self-harm

13.37

38.20

2.1

1.8

—

Personality disorders

10.54

37.49

1.8

2.2

—

All anxiety disorders

7.41

37.03

2.0

—

Specific personality disorders

11.55

36.90

1.9

2.2

—

Poisoning by medicine

13.24

34.79

2.2

1.9

—

Neurotic, stress-related and somatoform disorders

6.39

32.98

2.0

—

Anxiety disorders

6.37

32.80

2.0

—

Substance abuse

7.05

29.31

2.3

1.8

—

Psychiatric diseases

+∞

28.81

1.9

0.0

—

Mental and behavioural disorders due to psychoactive substance use

6.84

28.36

2.3

1.8

—

Selective serotonin reuptake inhibitors

7.31

24.58

2.1

1.9

—

Nonorganic sleeping disorders, excluding more controls

+∞

22.92

2.1

0.0

—

Other antidepressants

6.30

19.10

2.0

1.9

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

14.54

17.56

2.1

2.0

—

Mental and behavioural disorders due to alcohol

5.96

17.47

2.5

1.7

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

6.49

17.33

2.2

1.7

—

Alcohol use disorder, ICD-based

6.59

16.99

2.2

1.7

—

Emotionally unstable personality disorder

13.94

14.98

2.0

2.2

—

Other and unspecified mood [affective] disorders

31.83

14.79

2.6

2.5

—

Persons encountering health services in other circumstances

5.75

14.33

1.6

2.1

—

Alcohol use disorder, Swedish definition

5.00

13.86

2.2

1.7

—

4.61

13.73

2.5

1.8

—

4.75

13.45

2.5

1.7

—

Substance use, excluding alcohol

10.44

13.20

1.8

—

Type 2 diabetes, wide definition

5.60

12.61

1.9

—

Use of biperiden

24.45

12.46

2.4

2.1

—

Hyperkinetic disorders, excluding more controls

+∞

12.29

1.7

0.0

—

Schizotypal disorder

+∞

11.48

1.5

0.0

—

Obesity

3.88

11.40

2.1

2.0

—

Obesity and other hyperalimentation

3.88

11.37

2.1

2.0

—

Nonorganic sleeping disorders

8.82

10.73

2.1

2.2

—

Anaemias

+∞

10.52

1.8

0.0

—

KRA_PSY_EATING, excluding more controls

+∞

10.40

2.2

0.0

—

Mental and behavioural disorders due to cannabinoids

18.95

10.27

1.5

1.6

—

Other nutritional deficiencies

3.61

10.26

2.1

2.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.75

10.20

1.7

2.2

—

Biguanides

3.66

9.93

1.9

2.0

—

Other symptoms and signs involving cognitive functions and awareness

9.61

1.8

2.1

—

Obesity due to excess calories

4.17

9.61

1.8

2.1

—

Other reaction to severe stress, and adjustment disorders

4.78

9.52

1.8

2.2

—

Implicit Sepsis

3.85

9.44

1.7

2.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.13

8.93

1.9

2.0

—

Implicit Sepsis

4.19

8.87

1.8

2.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.15

8.61

1.8

2.2

—

Use of hypnotics and sedatives

3.06

8.58

2.1

1.9

—

Alcohol abuse, main dg, excluding more controls

+∞

8.33

1.9

0.0

—

Generalized anxiety disorder

8.52

8.28

1.9

2.4

—

Convulsions, not elsewhere classified

6.59

8.25

2.1

2.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.07

8.23

2.0

2.1

—

Obesity, other/unspecified

4.53

8.10

2.2

—

Alcohol dependence

8.10

8.06

1.9

1.8

—

Other specified and unspecified personality disorders

13.04

7.87

1.7

1.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.99

7.74

1.7

2.2

—

Type 2 diabetes, definitions combined, including avohilmo

3.14

7.69

1.9

2.1

—

Type 2 diabetes, strict (exclude DM1)

3.12

7.44

1.8

2.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

9.37

7.27

1.8

—

Malaise and fatigue

4.37

7.27

1.8

2.1

—

Other (not insulin) diabetes medications

3.06

7.25

1.9

2.0

—

Speech and linguistic disorders, excluding more controls

+∞

7.12

2.3

0.0

—

Panic disorder

7.91

7.09

1.7

2.5

—

Non-invasive ventilation

+∞

6.98

1.7

0.0

—

Type 2 diabetes, definitions combined

3.03

6.92

1.8

2.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.60

6.46

1.8

2.4

—

Persons encountering health services in other circumstances, wide

2.76

6.40

1.8

2.2

—

Medical observation and evaluation for suspected diseases and conditions

3.55

6.30

2.0

2.4

—

Other symptoms and signs involving general sensations and perceptions

18.09

6.26

2.2

1.8

—

Sleep apnoea

2.84

6.24

2.1

2.0

—

Emotional disorders starting during childhood or adolecense, excluding more controls

+∞

6.19

2.2

0.0

—

Mental retardation, excluding more controls

+∞

6.18

2.8

0.0

—

Other disorders starting during childhood or adolecense, excluding more controls

+∞

6.15

1.5

0.0

—

Sleep apnoea, including avohilmo

2.68

6.08

2.2

1.9

—

Open wound of forearm

10.02

6.03

2.1

1.7

—

Type 2 diabetes

2.72

5.99

1.9

2.0

—

Obsessive-compulsive disorder

11.14

5.79

1.9

—

Persistent mood disorders

11.12

5.79

2.1

2.3

—

Abnormal involuntary movements

10.01

5.52

2.4

1.9

—

Organic, including symptomatic, mental disorders

7.12

5.49

2.2

1.8

—

Oedema, not elsewhere classified

7.75

5.28

1.5

2.2

—

Extrapyramidal and movement disorders

6.67

5.24

1.8

1.9

—

Phobic anxiety disorders

6.67

5.24

1.8

2.5

—

Secondary parkinsonism, excluding more controls

+∞

5.21

1.2

0.0

—

Diabetes medication

2.44

5.09

1.9

2.0

—

Diabetes, varying definitions

2.44

5.08

1.9

2.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.47

4.91

2.3

2.0

—

Diabetes mellitus

2.38

4.83

1.9

2.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

11.49

4.79

1.4

1.7

—

Amenorrhoea

11.45

4.78

2.5

2.0

—

Other eating disorders

9.02

4.78

2.2

1.6

—

Problems related to lifestyle

9.01

4.78

3.0

1.9

—

Disorders of psychological development

4.64

4.59

2.0

2.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

8.20

4.56

1.9

2.1

—

Mixed and other personality disorders

8.20

4.56

1.3

2.2

—

Antihypertensive medication - note that there are other indications

2.37

4.55

2.2

2.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

106

2.27

4.49

2.1

2.0

—

Implicit bacterial Sepsis

5.45

4.48

1.3

2.2

—

Syncope and collapse

4.14

4.38

1.9

2.0

—

Implicit bacterial Sepsis

5.74

4.32

1.4

2.1

—

Episodal and paroxysmal disorders

2.18

4.31

2.2

2.0

—

Constipation

2.70

4.27

1.9

2.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.06

4.26

1.5

2.3

—

Epilepsy

4.47

4.22

2.0

1.9

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.46

4.08

1.9

—

Renal tubulo-interstitial diseases

2.48

4.05

1.8

2.1

—

Bacterial Sepsis

4.66

3.98

1.3

2.1

—

Social phobias

6.44

3.98

1.6

2.2

—

Eating disorder

5.56

3.96

2.2

1.8

—

Covid-19 confirmed case

4.06

3.89

1.6

2.0

—

Disorders of refraction and accommodation

3.77

3.86

1.7

2.1

—

Chronic apical periodontitis

101

2.09

3.83

2.2

1.9

—

Visual disturbances

3.18

3.77

2.2

2.1

—

Examination and observation for other reasons

2.98

3.76

1.9

2.4

—

Diabetes, insulin treatment (Kela reimbursement)

2.32

3.75

1.9

—

Disturbance of activity and attention

4.21

3.73

1.7

1.9

—

Emotional disorders and disorders of social functioning with onset specific to childhood

8.62

3.73

2.0

1.8

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.58

3.73

1.9

2.3

—

Acute bronchitis

3.86

3.71

2.0

1.9

—

Eating disorders

5.00

3.68

2.2

2.0

—

Dissociative [conversion] disorders

10.03

3.50

1.8

1.7

—

Other extrapyramidal and movement disorders in other diseases

6.16

3.50

2.0

—

Benign neoplasms

131

0.29

3.49

2.1

2.0

—

Endocrine, nutritional and metabolic diseases

2.18

3.48

2.3

1.9

—

Acute alcohol intoxication, ICD10

4.55

3.42

2.8

2.0

—

Acute alcohol intoxication

4.55

3.42

2.8

1.8

—

Visual disturbances and blindness

2.98

3.40

2.2

2.0

—

Neoplasms

123

0.30

3.37

1.4

2.1

—

Hyperkinetic disorders

3.68

3.30

1.7

2.0

—

Sleep disorders (combined)

2.02

3.30

2.1

2.0

—

Viral hepatitis, IBD co-morbidity

8.59

3.26

1.5

1.9

—

Other mental disorders due to brain damage and dysfunction and to physical disease

8.58

3.26

2.8

2.0

—

Mental retardation, wide definition

8.54

3.25

2.8

1.7

—

Mental retardation

8.54

3.25

2.8

1.7

—

Sleep disorders

105

2.06

3.24

2.0

—

Myopia

4.74

3.23

1.8

1.9

—

Paralytic ileus and intestinal obstruction

6.36

3.18

1.4

2.1

—

Venous thromboembolism

3.79

3.16

1.6

2.0

—

Special screening examination for infectious and parasitic diseases

3.09

3.12

1.8

2.5

—

Diseases of the myoneural junction and muscle

7.51

3.05

2.0

1.9

—

Other or unspecified ileus, impaction or obstruction

7.50

3.05

1.5

2.0

—

Bacterial infection, other or unspecified

3.67

3.02

1.6

2.0

—

Infections of the skin and subcutaneous tissue

2.26

3.02

2.0

—

Influenza and pneumonia

112

1.93

3.01

1.9

2.0

—

Periapical abscess

2.75

2.98

1.9

1.8

—

Monoamine oxidase A inhibitors

10.01

2.98

1.8

2.0

—

Cutaneous abscess, furuncle and carbuncle

3.85

2.97

2.6

1.9

—

Bronchitis

107

1.94

2.97

2.1

1.9

—

General examination and investigation of persons without complaint and reported diagnosis

2.61

2.96

2.2

2.4

—

All pneumoniae

110

1.94

2.93

1.8

2.1

—

Glucagon-like peptide-1 (GLP-1) analogues

4.71

2.91

2.1

1.8

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

4.71

2.91

2.1

1.8

—

All influenza

3.70

2.87

2.3

1.8

—

Invasive ventilation

6.68

2.87

2.7

1.9

—

Fracture of lumbar spine and pelvis

5.38

2.86

1.4

1.9

—

Hypertension, essential

2.19

2.86

2.1

1.9

—

Emotional disorders starting during childhood or adolescence

6.62

2.85

2.2

1.8

—

Other disorders starting during childhood or adolescence

6.61

2.84

1.5

1.8

—

Other functional intestinal disorders

3.18

2.84

1.8

2.1

—

General symptoms and signs

1.95

2.83

2.0

2.1

—

Fracture of foot, except ankle

3.34

2.80

1.5

2.0

—

Alcohol abuse, main dg

4.45

2.79

1.9

2.0

—

Acute tubulo-interstitial nephritis

2.59

2.79

1.8

2.3

—

Pneumonias (Asthma/COPD co-morbidities)

108

1.93

2.79

1.8

2.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.02

2.78

1.9

2.0

—

2.02

2.78

1.9

2.0

—

Toxic effects of substances chiefly nonmedicinal as to source

5.01

2.72

1.4

2.0

—

Implicit viral Sepsis

5.00

2.72

1.7

2.1

—

Viral Sepsis

5.00

2.72

1.7

2.1

—

Statin medication

2.14

2.72

1.9

2.0

—

Event of undetermined intent

6.01

2.70

2.2

1.9

—

Maternal care for known or suspected abnormality of pelvic organs

0.00

2.68

0.0

2.1

—

Hypothyroidism, strict autoimmune

2.13

2.68

2.3

2.1

—

Care involving use of rehabilitation procedures

2.30

2.67

2.2

2.1

—

Implicit viral Sepsis

4.21

2.67

1.6

2.1

—

Other diseases of upper respiratory tract

109

0.33

2.67

2.3

2.0

—

Specific development disorders of scholastic skills

5.93

2.67

2.2

1.6

—

All kidney diseases

103

1.92

2.62

1.7

2.0

—

Renal failure

4.16

2.60

1.5

2.0

—

Other and unspecified myopathies

7.15

2.55

1.8

2.0

—

Pneumonitis due to solids and liquids

7.15

2.55

3.8

2.1

—

Delirium, not induced by alcohol and other psychoactive substances

7.13

2.54

1.6

2.0

—

5.46

2.54

1.3

1.9

—

Anorexia (incl.atypical)

5.46

2.54

2.3

1.8

—

Disorders of the thyroid gland

1.95

2.53

2.4

2.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

3.02

2.52

1.5

2.0

—

Dental pulpitis, including avohilmo

113

1.84

2.52

2.2

2.0

—

Erysipelas

2.87

2.51

1.6

1.7

—

Erysipelas

2.39

2.50

1.4

1.9

—

Bacterial infection, other or unspecified

3.00

2.45

1.6

1.9

—

Other strabismus

3.80

2.45

2.4

1.9

—

Codes for special purposes

2.23

2.42

1.6

2.1

—

Provisional assignment of new diseases of uncertain etiology

2.23

2.42

1.6

2.1

—

Carpal tunnel syndrome

0.00

2.42

0.0

2.2

—

Chronic viral hepatitis

5.01

2.40

1.5

2.0

—

Other viral hepatitis

5.01

2.40

1.5

2.0

—

Viral hepatitis

5.01

2.40

1.5

2.0

—

Other bacterial diseases

1.99

2.40

1.5

2.1

—

Anankastic personality disorder

6.27

2.37

1.6

1.8

—

Acute renal failure

6.25

2.37

1.0

1.6

—

Cellulitis

3.64

2.36

1.6

2.0

—

Intestinal stricture

4.12

2.36

1.4

1.9

—

Focal epilepsy

4.12

2.35

2.3

2.0

—

Dizziness and giddiness

2.38

2.34

1.5

2.2

—

Asthma/COPD (KELA code 203)

131

0.37

2.34

1.3

2.1

—

Non-selective monoamine reuptake inhibitors

4.82

2.33

1.8

2.0

—

Candidiasis

3.22

2.30

2.1

2.3

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

108

1.83

2.30

1.8

2.1

—

Asthma, hospital admissions , main diagnosis only

137

0.32

2.29

1.6

2.0

—

Other gastritis (incl. Duodenitis)

4.62

2.27

1.8

1.9

—

GI-bleeding

4.62

2.27

1.5

2.0

—

Nerve, nerve root and plexus disorders

114

0.38

2.24

1.3

2.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.91

2.22

2.4

2.1

—

Nausea and vomiting

3.41

2.22

2.0

2.2

—

Heterophoria

5.56

2.21

2.8

1.7

—

Lung diseases due to external agents

5.56

2.21

3.8

1.9

—

Missing teeth due to accident, extraction or parodontitis

2.85

2.18

2.3

1.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.94

2.17

2.2

2.1

—

Retention of urine

4.48

2.15

1.7

1.9

—

Other diseases of the digestive system

4.29

2.15

1.5

1.9

—

Irritable bowel syndrome

3.00

2.14

2.4

2.2

—

Single delivery by forceps and vacuum extractor

0.00

2.13

0.0

2.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.22

2.11

1.5

1.8

—

Heart failure, not strict

2.55

2.08

1.8

—

Persons encountering health services for specific procedures, not carried out

5.00

2.07

1.6

2.0

—

Viral pneumonia

5.00

2.07

1.8

1.9

—

Unspecified lump in breast

5.00

2.07

2.2

1.9

—

Diseases of the digestive system

2.89

2.05

2.3

1.9

—

Finngen Rheumatological endpoints

119

0.43

2.05

2.0

—

Abnormalities of heart beat

2.85

2.02

1.4

2.2

—

Exposure to unspecified factor

120

1.74

2.01

1.9

2.0

—

Nutritional anaemias

3.08

2.00

1.9

2.2

—

Hypothyroidism, other/unspecified

1.86

2.00

2.3

2.0

—

Pneumonia, organism unspecified

1.85

2.00

2.0

2.1

—

Irregular menses

2.03

1.99

2.2

2.1

—

Symptoms and signs involving the urinary system

2.20

1.99

1.9

—

Other bacterial diseases

101

1.76

1.97

1.4

2.1

—

Exclusions for E4_PCOS_CONSORTIUM

1.87

1.95

1.9

2.1

—

Persons encountering health services in circumstances related to reproduction

107

0.38

1.95

1.5

1.9

—

Post-traumatic stress disorder

4.55

1.94

2.0

2.3

—

3.75

1.93

1.2

2.3

—

Diagnoses used for exclusion with ILD

3.75

1.93

3.5

2.1

—

Other acute lower respiratory infections

2.19

1.92

2.0

2.2

—

Hypertensive diseases (excluding secondary)

2.05

1.91

2.2

2.1

—

Mycoses

123

1.77

1.90

2.4

1.9

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.00

1.88

0.0

2.0

—

Injuries to the elbow and forearm

1.89

1.87

1.8

2.2

—

Insomnia

114

1.73

1.84

2.0

—

Iron deficiency anaemia

3.14

1.84

1.9

2.2

—

Focal epilepsy, strict definition

3.53

1.83

1.7

2.0

—

Pulmonary heart disease, diseases of pulmonary circulation

3.53

1.83

1.7

2.1

—

Other bacterial intestinal infections

4.17

1.82

1.8

2.1

—

Certain conditions originating in the perinatal period

3.55

1.81

1.5

—

Erosion of teeth , including avohilmo

2.57

1.80

2.0

—

Speech and linguistic disorders

3.06

1.79

2.3

1.8

—

DVT of lower extremities and pulmonary embolism

3.03

1.79

1.7

2.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.73

1.77

1.9

2.1

—

Prolonged pregnancy

0.00

1.72

0.0

2.2

—

Diseases of liver

2.92

1.72

2.6

1.9

—

Strabismus

2.66

1.71

2.4

1.9

—

Use of disulfiram, acamprosate or naltrexone

3.85

1.71

1.6

2.0

—

Somatoform disorder

3.85

1.71

2.4

2.0

—

Pregnancy with abortive outcome

0.36

1.71

2.0

2.2

—

Deep bite

3.29

1.69

1.7

1.8

—

Diseases of pulp and periapical tissues, including avohilmo

1.71

1.67

2.4

2.0

—

Subjective visual disturbances

3.16

1.66

1.7

1.9

—

Neurological diseases

1.70

1.63

2.3

2.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.20

1.63

1.8

—

Pain in thoracic spine

3.57

1.61

1.6

1.9

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.38

1.61

1.8

2.0

—

Necrosis of pulp, including avohilmo

1.83

1.59

2.0

—

Intestinal infectious diseases

119

1.66

1.59

1.9

2.0

—

Other fall from one level to another

2.69

1.58

2.0

1.9

—

Fracture of skull and facial bones

2.43

1.53

1.8

1.9

—

Inflammatory bowel disease treatment related agents

132

0.51

1.52

1.5

2.1

—

Acute upper respiratory infections

1.65

1.52

2.0

—

Viral warts

2.59

1.51

2.3

2.0

—

Pain in limb

101

1.66

1.50

1.8

2.1

—

Dementia, including avohilmo

3.44

1.48

2.4

1.7

—

Cardiovascular diseases

1.63

1.47

2.1

—

Viral infections characterized by skin and mucous membrane lesions

2.22

1.46

1.7

2.1

—

Other condition

3.13

1.44

2.0

1.9

—

Assault

2.73

1.43

2.2

1.9

—

Gastro-oesophageal reflux disease

1.92

1.40

2.6

2.1

—

Open wound of wrist and hand

1.86

1.40

2.0

2.1

—

Other sexually transmitted chlamydial diseases

2.42

1.39

1.4

2.1

—

Diseases of external ear

2.41

1.39

2.1

1.9

—

Other disorders of urethra and urinary system

1.83

1.37

2.0

2.2

—

Otitis externa

2.61

1.36

2.2

1.9

—

Pulmonary embolism

2.94

1.36

1.8

2.1

—

Pulmonary heart disease

2.94

1.36

1.8

2.1

—

Other/unspecified dorsalgia

2.18

1.35

1.7

2.0

—

First line medication for Crohn's disease

129

0.54

1.35

1.6

2.1

—

Hypertensive diseases

1.71

1.32

2.0

1.9

—

Hypertension

1.71

1.32

2.0

1.9

—

Persons encountering health services for examination and investigation

1.95

1.31

2.1

2.4

—

Injuries to the hip and thigh

2.41

1.30

1.8

—

Open wound of head

1.90

1.30

1.8

1.9

—

Migraine

1.78

1.28

1.9

2.0

—

Other bacterial intestinal infections

2.78

1.28

1.8

1.9

—

Unspecified haematuria

2.49

1.27

1.7

2.0

—

Migraine without aura

2.29

1.26

2.0

—

Injuries to the ankle and foot

122

1.60

1.26

1.7

2.1

—

Conjunctivitis (acute, non atopic)

2.21

1.23

1.6

2.1

—

Oral corticosteroids

114

0.52

1.23

1.5

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

111

1.54

1.22

1.8

2.0

—

Pilonidal cyst

2.63

1.21

1.4

2.1

—

Other diseases of intestines

114

1.50

1.20

1.9

2.1

—

Diseases of inner ear

2.15

1.20

1.5

2.1

—

Polyarthropathies

0.46

1.20

1.8

2.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

121

0.55

1.20

1.7

2.0

—

ILD medications

131

0.58

1.19

1.8

2.0

—

Angina pectoris

0.00

1.19

0.0

1.8

—

Melanocytic naevi

0.00

1.16

0.0

2.1

—

Other and unspecified urticaria

2.50

1.15

1.4

1.8

—

Congenital malformations and deformations of the musculoskeletal system

2.49

1.14

1.4

1.9

—

Haemorrhage from respiratory passages

2.50

1.14

1.4

2.1

—

Transient ischemic attack

2.53

1.14

1.2

2.1

—

Bacterial pneumoniae

2.37

1.13

1.4

1.8

—

Dermatitis and eczema

117

1.48

1.11

1.9

2.0

—

Complications of labour and delivery

0.47

1.10

2.2

2.1

—

Dermatitis

1.77

1.09

1.8

2.1

—

Soft tissue disorders related to use, overuse and pressure

2.38

1.09

2.0

—

All chronic kidney diseases

2.20

1.08

2.0

1.8

—

Chronic periodontitis, complicated

1.93

1.07

1.6

1.9

—

Caries of enamel

115

1.51

1.05

2.1

2.0

—

Fever of other and unknown origin

1.81

1.05

1.4

2.2

—

Diseases of salivary glands

2.12

1.05

2.1

2.0

—

Asthma (only as main-diagnosis), excluding more controls

0.45

1.05

1.6

2.0

—

Asthma (only as main-diagnosis)

0.45

1.05

1.6

2.1

—

Diseases of oesophagus, stomach and duodenum

100

1.49

1.03

2.2

2.0

—

Urolithiasis

2.27

1.03

1.6

2.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.03

0.0

2.2

—

Bacterial pneumonia (organism specified)

2.05

1.02

1.4

1.8

—

Redundant prepuce, phimosis and paraphimosis

2.04

1.01

1.3

2.2

—

Injuries to the wrist and hand

123

1.46

1.01

1.8

2.0

—

Superficial injury of lower leg

2.00

1.00

2.0

1.9

—

Other diseases of urinary system

1.53

0.99

2.0

2.1

—

Gonarthrosis, primary, with knee surgery

0.00

0.99

0.0

1.7

—

Factors influencing health status and contact with health services

2.07

0.99

2.0

2.6

—

Intestinal infectious diseases

111

1.44

0.97

1.8

2.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

104

1.56

0.96

1.9

—

Other and unspecified dermatitis

1.85

0.96

1.8

2.1

—

Used for control exclusion in common control thyroid runs

103

1.42

0.93

2.4

2.0

—

Other disorders of lacrimal gland

2.22

0.93

2.3

1.9

—

Exposure to other specified factors

122

1.50

0.93

2.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1.84

0.91

1.9

2.1

—

Polycystic ovarian syndrome, consortium definition

1.54

0.91

2.2

2.1

—

Effects of foreign body entering through natural orifice

2.14

0.91

1.7

1.9

—

Bacterial pneumonia, not elsewhere classified

2.11

0.90

1.5

1.9

—

Disorders of vestibular function (Vertigo)

2.11

0.90

1.7

2.2

—

Fall on same level involving ice and snow

1.75

0.90

1.8

2.1

—

Chronic lower respiratory diseases

131

0.65

0.90

1.6

2.1

—

Headache

1.58

0.89

1.7

2.1

—

Asthma (diagnoses ohter than nonallergic)

129

0.58

0.89

1.6

2.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.83

0.85

1.5

2.7

—

Acute laryngitis and tracheitis

1.97

0.85

1.5

2.0

—

Migraine with aura and triptan purchases

1.94

0.84

1.8

2.5

—

Appendectomy

107

1.52

0.84

2.2

1.9

—

Dyspnoea

1.51

0.84

1.7

2.0

—

Anomalies of dental arch relationship, including avohilmo

1.93

0.84

1.7

2.3

—

Disorders of thyroid, IBD co-morbidities

1.92

0.82

3.3

2.3

—

Dental caries, including avohilmo

1.70

0.81

2.2

2.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

1.71

0.81

1.9

2.1

—

Other maternal disorders predominantly related to pregnancy

0.56

0.80

2.6

2.1

—

Other medical care

0.00

0.79

0.0

1.8

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.79

0.0

1.9

—

Insulin medication

1.68

0.79

2.0

1.8

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.79

0.0

2.4

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.69

0.79

2.1

2.4

—

Urticaria and erythema

1.67

0.78

1.4

2.2

—

Diabetic nephropathy, excluding more controls

0.00

0.78

0.0

1.7

—

Unspecified fall

1.70

0.76

2.0

—

Dorsalgia

110

1.36

0.75

2.1

2.0

—

Other headache syndromes

1.70

0.75

1.6

2.0

—

Atopic dermatitis

101

1.46

0.74

2.1

—

Stomatitis and related lesions

2.08

0.74

1.8

—

Diseases of oral cavity, salivary glands and jaws

1.65

0.74

2.1

2.0

—

Crowding of teeth, including avohilmo

2.07

0.74

1.8

1.7

—

Fracture of shoulder and upper arm

1.84

0.73

2.1

2.0

—

Disorders of breast

1.64

0.73

2.1

—

Any event in cancer register

0.62

0.72

2.0

—

Superficial injury of head

2.00

0.72

1.8

1.9

—

Migraine with aura

1.80

0.72

1.9

2.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

107

0.54

0.72

2.3

2.1

—

Bleeding

1.57

0.71

1.5

1.9

—

Urticaria

1.75

0.71

1.3

2.3

—

Explicit Sepsis

1.94

0.71

1.2

2.1

—

Myalgia

1.92

0.70

1.4

2.3

—

Other chronic obstructive pulmonary disease, including avohilmo

1.88

0.69

1.4

2.0

—

Shoulder lesions

0.51

0.69

1.2

2.0

—

Metabolic disorders

1.44

0.68

2.1

1.9

—

Other soft tissue disorders, not elsewhere classified

108

1.36

0.68

1.7

2.1

—

Diseases of male genital organs

1.56

0.66

1.4

2.0

—

Diseases of the eye and adnexa

103

0.68

0.66

1.6

2.0

—

Dermatophytosis

1.51

0.65

2.5

1.9

—

Diabetes mellitus in pregnancy

0.57

0.64

3.0

2.1

—

Abrasion of teeth

1.72

0.64

1.2

2.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

121

0.67

0.63

1.9

2.1

—

Triptan medication for migraine, single purchase ok

121

0.67

0.63

1.9

2.1

—

Autoimmune diseases

108

1.32

0.63

2.3

2.0

—

Other disorders of veins

1.71

0.63

1.4

2.3

—

Heart failure and coronary heart disease

0.00

0.62

0.0

1.7

—

Presence of cardiac and vascular implants and grafts

0.00

0.61

0.0

1.6

—

Covid-19 suspected case

1.67

0.61

1.4

2.1

—

Cystitis

1.42

0.61

1.8

2.2

—

Early lumbar disc prolapse, operated

0.00

0.60

0.0

1.9

—

Early lumbar disc prolapse operation

0.00

0.60

0.0

2.0

—

Mucosal proctocolitis

0.00

0.60

0.0

1.9

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.60

0.0

1.8

—

Ulcerative colitis, NAS

0.00

0.60

0.0

2.0

—

ILD medications: azathioprine

0.00

0.60

0.0

2.0

—

Azathioprine

0.00

0.60

0.0

2.0

—

Asthma and allergy, excluding more controls

0.00

0.60

0.0

2.0

—

Female infertility, associated with anovulation

0.00

0.59

0.0

2.3

—

Injuries to the head

122

1.31

0.59

1.9

2.0

—

Spondylopathies (FG)

0.00

0.59

0.0

2.0

—

Neurological diseases, wide definition

1.58

0.59

2.3

—

Anti-inflammatory and antirheumatic products, non-steroids

0.55

0.59

1.8

2.1

—

Asthma and allergy

0.00

0.59

0.0

2.1

—

Persons encountering health services for specific procedures and health care

119

1.31

0.59

2.0

—

Abnormal findings on antenatal screening of mother

0.00

0.58

0.0

2.1

—

Ischemic heart diseases

0.57

0.58

1.4

1.8

—

Spondyloarthritis

0.00

0.58

0.0

2.0

—

Diabetic nephropathy

0.00

0.58

0.0

2.1

—

Dentofacial anomalies [including malocclusion]

112

1.36

0.57

1.7

2.1

—

Type of accident

1.71

0.57

2.0

1.8

—

Allergic conjunctivitis

113

0.60

0.57

2.1

—

Disorders of other endocrine glands

1.48

0.57

1.3

2.2

—

Arthropathies

118

0.73

0.57

2.2

2.1

—

Injuries to the thorax

1.62

0.55

2.2

1.8

—

Dislocation, sprain and strain of joints and ligaments of knee

115

0.64

0.54

1.9

2.0

—

Superficial injury of wrist and hand

1.58

0.54

1.3

1.9

—

Other diseases of lip and oral mucosa

1.58

0.54

3.3

1.8

—

Disorders of lacrimal system

1.57

0.54

2.3

2.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.54

0.53

2.0

1.8

—

Complications of surgical and medical care, not elsewhere classified

109

0.69

0.52

2.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.46

0.52

1.8

2.2

—

Excessive attrition of teeth

0.61

0.51

1.8

2.0

—

Diseases of the musculoskeletal system and connective tissue

0.69

0.51

2.0

2.2

—

Arthrosis

0.63

0.50

1.4

2.0

—

COPD/asthma/ILD related infections

1.31

0.50

2.2

2.0

—

COPD/asthma related infections

1.31

0.50

2.2

2.0

—

Contraceptive management

0.63

0.49

1.4

2.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.57

0.49

2.3

1.9

—

Cough

1.54

0.48

1.9

2.3

—

STROKE

1.49

0.47

1.4

1.8

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.42

0.46

1.8

2.2

—

Genitourinary diseases

1.36

0.46

1.8

2.1

—

Disorders of synovium and tendon

0.59

0.45

1.8

2.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.41

0.45

1.7

2.2

—

Medical abortion

0.70

0.45

1.6

2.2

—

Insulin, intermediate and long-acting

1.39

0.44

2.0

1.8

—

Low back pain

1.31

0.43

2.1

2.0

—

Other neurological diseases

1.46

0.43

1.3

2.1

—

Gestational diabetes (for exclusion)

0.64

0.43

3.0

2.1

—

Cerebrovascular diseases (FINNGEN)

1.61

0.43

1.6

1.8

—

Diseases of pulp and periapical tissues and dental caries

1.41

0.43

2.3

2.0

—

Inflammatory diseases of female pelvic organs

1.35

0.42

1.6

2.2

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.41

0.42

2.0

1.8

—

Abnormalities of breathing

101

1.27

0.42

1.7

2.1

—

Viral and other specified intestinal infections

1.39

0.42

2.0

2.2

—

Pain in throat and chest

1.28

0.41

1.8

2.2

—

Other metabolic disorders

0.00

0.41

0.0

2.0

—

Thyrotoxicosis with diffuse goitre

0.00

0.41

0.0

1.8

—

Lichen planus, including avohilmo

0.00

0.41

0.0

1.8

—

Fibroblastic disorders

0.00

0.41

0.0

1.9

—

Eustachian salpingitis and obstruction

0.00

0.41

0.0

1.9

—

Infections of genitourinary tract in pregnancy

0.00

0.41

0.0

2.2

—

Graves disease, strict definition

0.00

0.41

0.0

2.0

—

Postpartum haemorrhage due to anatomy

0.00

0.41

0.0

2.5

—

Other (seronegative) rheumatoid arthritis, wide

0.00

0.41

0.0

1.9

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.41

0.0

1.9

—

Concussion

1.38

0.41

1.9

2.1

—

Unstable angina pectoris

0.00

0.41

0.0

2.0

—

Methotrexate

0.00

0.40

0.0

1.9

—

Diabetic neuropathy

0.00

0.40

0.0

2.1

—

Pure hypercholesterolaemia

1.34

0.40

2.0

1.8

—

Papulosquamous disorders

1.47

0.40

2.2

1.8

—

Nonsuppurative otitis media

1.33

0.40

1.9

2.1

—

Impingement syndrome of shoulder

0.00

0.40

0.0

1.9

—

1.25

0.40

2.2

2.0

—

Codeine or tramadol medication

113

0.77

0.40

1.7

2.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

0.39

0.0

1.9

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.39

0.0

2.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.35

0.38

1.7

2.2

—

Any death

1.38

0.37

3.0

2.0

—

Symptoms and signs involving the circulatory and respiratory systems

102

1.23

0.37

1.8

2.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.36

0.37

2.4

2.2

—

Leiomyoma of uterus

0.62

0.37

1.6

2.2

—

Tramadol

0.71

0.36

1.8

2.0

—

Fracture of forearm

1.27

0.36

1.4

2.2

—

Keratitis

1.40

0.35

2.0

—

Any gastric operation

1.24

0.34

1.9

2.0

—

GASTRO-related operations

1.24

0.34

1.9

2.0

—

Cerebrovascular diseases

1.36

0.34

1.7

1.9

—

Other joint disorders

118

0.80

0.34

2.2

2.1

—

Asthma-related infections

0.69

0.33

1.2

2.2

—

Asthma, hospital admission 2, infections

0.69

0.33

1.2

2.2

—

Disorders of gallbladder, biliary tract and pancreas

0.75

0.32

1.5

2.0

—

Hard cardiovascular diseases

0.72

0.32

1.6

1.9

—

Dental operations

1.33

0.31

2.4

2.1

—

Injury, poisoning and certain other consequences of external causes

1.34

0.31

1.7

2.4

—

Disease of hard tissues of teeth, NOS

1.31

0.31

1.7

2.0

—

All dysplastic lesions of the cervix uteri

1.33

0.31

2.1

2.2

—

Other diseases of hard tissues of teeth

1.29

0.31

2.0

—

Menorrhagia

1.29

0.31

1.4

1.9

—

Caries of dentine, including avohilmo

1.34

0.30

1.9

2.0

—

Other disorders of ear

0.75

0.29

2.4

1.9

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.23

0.29

2.1

—

Solid cancers, helper endpoint

0.75

0.28

2.1

2.0

—

Complications of procedures, not elsewhere classified

0.77

0.27

1.8

2.0

—

Parasetamol

1.21

0.27

2.3

2.1

—

Disorders of choroid and retina

0.68

0.26

1.4

1.9

—

Other heart diseases, wide

112

0.82

0.26

1.6

2.0

—

0.71

0.26

1.2

2.2

—

Other heart diseases

1.20

0.25

1.6

2.1

—

Gastrointestinal diseases

1.23

0.25

2.0

2.1

—

Autoimmune diseases related-to ILD

127

0.81

0.24

2.0

—

Contact with and exposure to communicable diseases

0.71

0.24

1.8

2.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.20

0.23

1.8

2.0

—

Congenital malformations, deformations and chromosomal abnormalities

123

1.20

0.23

1.8

2.0

—

Migraine without aura and triptan purchases

1.28

0.23

2.0

2.4

—

Disturbances of skin sensation

1.28

0.23

1.8

2.3

—

Disorders of skin appendages

0.77

0.22

2.3

2.0

—

Mouth breathing

1.25

0.22

1.8

1.7

—

Malignant neoplasm of prostate, including Hilmo

0.00

0.22

0.0

2.1

—

malignant neoplasm of male genital organs

0.00

0.22

0.0

2.1

—

Other and unspecified effects of external causes

1.22

0.22

3.2

2.0

—

Soft tissue disorders

112

1.15

0.22

1.8

2.1

—

Status post-ami

0.00

0.22

0.0

2.0

—

Malignant neoplasm

0.80

0.22

2.0

—

Lower back pain or/and sciatica

118

1.16

0.21

2.0

—

Degenerative diseases of the nervous system

0.00

0.21

0.0

1.9

—

Diseases of the ear and mastoid process

122

0.86

0.21

2.0

—

Pacemaker

0.00

0.21

0.0

1.8

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

0.21

0.0

1.8

—

Excessive earwax

1.19

0.21

1.4

1.7

—

Golimumab

0.00

0.21

0.0

2.0

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

0.00

0.21

0.0

2.0

—

Ankylosing spondylitis, strict definition

0.00

0.21

0.0

2.0

—

Maternal care for known or suspected disproportion

0.00

0.21

0.0

2.0

—

Meningitis

0.00

0.21

0.0

2.0

—

Scabies

0.00

0.21

0.0

2.0

—

Other and unspecified coagulation defects

0.00

0.21

0.0

2.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

0.21

0.0

2.1

—

Juvenile arthritis (FINNGEN)

0.00

0.21

0.0

1.7

—

Labour and delivery complicated by umbilical cord complications

0.00

0.21

0.0

2.0

—

Sacroiliitis, not elsewhere classified

0.00

0.21

0.0

1.9

—

Desensitization to allergens

0.00

0.21

0.0

1.8

—

Other ulcerative colitis

0.00

0.21

0.0

2.0

—

Cerebral cysts

0.00

0.21

0.0

2.0

—

Pediculosis, acariasis and other infestations

0.00

0.21

0.0

2.0

—

Hordeolum and other deep inflammation of eyelid

0.00

0.21

0.0

1.9

—

Scleritis and episcleritis

0.00

0.21

0.0

2.1

—

Other/unspecified reactive arthropathies

0.00

0.21

0.0

2.0

—

Hypoglycaemia, other or unspecified

0.00

0.21

0.0

1.9

—

Dislocation, sprain and strain of joints and ligaments of elbow

0.00

0.21

0.0

2.0

—

Dermatographic urticaria

0.00

0.21

0.0

2.0

—

Other osteochondropathies

0.00

0.21

0.0

2.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

2.0

—

Reactive arthropathies, FINNGEN

0.00

0.21

0.0

1.9

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

2.1

—

Inflammatory diseases of the central nervous system

0.00

0.21

0.0

2.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.21

0.0

2.0

—

Viral infections of the central nervous system

0.00

0.21

0.0

2.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.21

0.0

2.0

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.21

0.0

1.9

—

Other peripheral vascular diseases

0.00

0.21

0.0

1.8

—

Haemangioma, any site

0.00

0.21

0.0

1.8

—

Benign neoplasm of bone and articular cartilage

0.00

0.21

0.0

2.2

—

Nail disorders

0.00

0.21

0.0

2.0

—

Ulcerative rectosigmoiditis

0.00

0.21

0.0

2.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.21

0.0

1.8

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

2.0

—

Suggestive for eosinophilic asthma

0.00

0.21

0.0

2.0

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

1.9

—

Reactive arthropathies

0.00

0.21

0.0

2.0

—

Deep endometriosis

0.00

0.21

0.0

1.9

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

1.9

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.21

0.0

1.9

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

1.9

—

Other and unspecified visual disturbances

0.00

0.21

0.0

2.0

—

Flat foot [pes planus] (acquired)

0.00

0.21

0.0

1.9

—

Plantar fascial fibromatosis

0.00

0.21

0.0

1.9

—

Pruritus

0.00

0.21

0.0

2.1

—

Chalazion

0.00

0.21

0.0

2.1

—

Other/unspecified rheumatoid arthritis

0.00

0.21

0.0

1.7

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.21

0.0

2.0

—

Benign neoplasm: Ascending colon

0.00

0.21

0.0

1.8

—

Hallux rigidus

0.00

0.21

0.0

2.1

—

Benign leiomyoma with endometriosis

0.00

0.21

0.0

1.8

—

Benign neoplasm: Rectum

0.00

0.21

0.0

1.8

—

Adhesive capsulitis of shoulder

0.00

0.21

0.0

2.0

—

Malignant melanoma, including Hilmo

0.00

0.21

0.0

1.9

—

Septal defects

0.00

0.21

0.0

1.9

—

Congenital malformations of cardiac septa

0.00

0.21

0.0

1.9

—

Polyhydramnios

0.00

0.21

0.0

2.4

—

Open bite

0.00

0.21

0.0

1.8

—

Ankylosing spondylitis, ICD10

0.00

0.21

0.0

2.2

—

Fibromyalgia

0.00

0.21

0.0

1.9

—

Other benign neoplasms of connective and other soft tissue

0.00

0.21

0.0

2.2

—

Superficial injury of forearm

0.00

0.21

0.0

1.9

—

L04AD Calcineurin inhibitors

0.00

0.21

0.0

1.9

—

Melanocytic naevi of trunk

0.00

0.21

0.0

2.2

—

Lichen planus

0.00

0.21

0.0

1.8

—

Trigger finger

0.00

0.21

0.0

1.9

—

Colectomy operation

0.00

0.21

0.0

1.9

—

Benign neoplasm: Sigmoid colon

0.00

0.21

0.0

1.8

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

1.8

—

Pollen allergy

1.18

0.21

2.4

2.2

—

Sequelae of cerebrovascular disease

0.00

0.21

0.0

1.9

—

Other obstetric conditions, not elsewhere classified

1.25

0.21

2.5

2.2

—

Inflammatory bowel disease

1.16

0.21

1.6

1.9

—

Acute bronchiolitis

0.00

0.21

0.0

2.3

—

Other coagulation defects

0.00

0.21

0.0

2.1

—

Other obstructed labour

0.00

0.21

0.0

1.8

—

Raynaud syndrome

0.00

0.21

0.0

2.1

—

Ankylosing spondylitis

0.00

0.21

0.0

2.1

—

Cervicocranial syndrome

0.00

0.21

0.0

2.0

—

Seronegative rheumatoid arthritis

0.00

0.21

0.0

1.9

—

Other disorders of conjunctiva

0.00

0.21

0.0

1.9

—

Chronic laryngitis and laryngotracheitis

0.00

0.21

0.0

1.8

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.21

0.0

1.8

—

Noninfectious colitis NAS

0.00

0.21

0.0

2.1

—

Seborrhoeic keratosis

0.00

0.21

0.0

2.1

—

Cardiodefibrillation

0.00

0.21

0.0

1.8

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.20

0.0

1.6

—

Dysplasia of cervi uteri

1.24

0.20

2.3

2.1

—

Actinic keratosis

0.00

0.20

0.0

1.7

—

Postprocedural disorders of nervous system

0.00

0.20

0.0

2.0

—

Family history of malignant neoplasm

0.00

0.20

0.0

1.9

—

FESS (DNB20)

0.00

0.20

0.0

2.1

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.20

0.0

2.1

—

Ethmoidectomy

0.00

0.20

0.0

2.1

—

Lateral epicondylitis

0.00

0.20

0.0

2.1

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

0.20

0.0

2.0

—

Other skin changes

0.00

0.20

0.0

1.9

—

Blepharochalasis

0.00

0.20

0.0

1.8

—

Asthma

0.81

0.20

1.6

2.1

—

Acute suppurative otitis media

1.24

0.19

3.1

2.0

—

Accidents

0.83

0.19

1.9

2.2

—

Diverticular disease of intestine

1.16

0.19

2.0

2.1

—

Autoimmune diseases excluding thyroid diseases

108

0.86

0.19

1.6

2.0

—

Asthma (mode)

0.81

0.19

1.6

2.1

—

Osteopathies and chondropathies

1.14

0.19

1.8

2.0

—

Asthma, excluding more controls

0.81

0.18

1.6

2.0

—

Pain in joint

1.20

0.18

2.0

2.1

—

External causes of morbidity and mortality

1.21

0.18

1.7

2.4

—

Other disorders of skin and subcutaneous tissue

1.20

0.18

1.4

2.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

107

0.85

0.18

1.9

—

Codeine

101

0.86

0.18

1.7

2.0

—

Ovarian cyst

0.76

0.17

1.8

2.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

107

0.87

0.17

1.6

2.0

—

Asthma, unspecified (mode)

1.18

0.17

1.3

2.1

—

Asthma, unspecified (mode), excluding more controls

1.17

0.16

1.3

2.1

—

Certain infectious and parasitic diseases

1.14

0.16

1.7

2.2

—

Viral and other specified intestinal infections

1.12

0.16

2.0

2.2

—

Maternal care for other known or suspected fetal problems

0.74

0.16

1.8

2.2

—

Disorders of sclera, cornea, iris and ciliary body

1.11

0.16

2.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.11

0.15

1.8

—

Intracranial injury

1.13

0.15

2.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.82

0.14

1.3

1.9

—

Disorders of conjunctiva

129

0.87

0.14

1.9

2.0

—

Malignant neoplasm, wide definition for exclusion

0.85

0.14

1.9

2.0

—

Intracranial trauma

1.17

0.14

1.9

2.0

—

Chronic periodontitis, including avohilmo

1.14

0.13

1.8

2.0

—

COPD differential diagnosis

1.14

0.12

1.9

2.1

—

ILD differential diagnosis

1.14

0.12

1.9

2.1

—

Periodontitis

1.13

0.11

1.8

2.0

—

Falls/tendency to fall

110

1.09

0.11

1.8

2.1

—

Fall on same level

125

0.92

0.10

1.7

2.1

—

Gingivitis and periodontal diseases

1.12

0.10

2.1

1.9

—

Injuries to the knee and lower leg

127

0.92

0.10

2.0

—

Other viral diseases, not elsewhere classified

1.13

0.10

1.4

2.1

—

Varicose veins

1.11

0.10

1.6

2.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.09

0.09

1.6

2.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

1.09

0.09

1.4

2.0

—

Other specific joint derangements/joint disorders

114

0.91

0.09

2.1

2.0

—

Opioids

113

0.92

0.09

1.9

2.0

—

Sensorineural hearing loss

1.10

0.09

2.0

1.8

—

Other external causes of accidental injury

0.90

0.09

2.0

2.2

—

Rotator cuff syndrome

0.78

0.08

1.2

2.1

—

Chronic sinusitis

0.77

0.08

1.0

2.0

—

Impacted teeth

1.07

0.08

2.1

2.2

—

Atopic dermatitis, strict definition with reimbursement

0.83

0.07

1.8

2.2

—

Atopic dermatitis, strict definition

0.82

0.07

1.8

2.2

—

Pain (limb, back, neck, head abdominally)

0.90

0.07

1.8

2.2

—

Fracture of lower leg, including ankle

1.03

0.07

2.1

1.8

—

Embedded and impacted teeth

0.82

0.07

1.7

2.1

—

Vasomotor and allergic rhinitis

0.85

0.07

2.1

2.2

—

Other and unspecified tonsillitis

1.08

0.07

1.9

2.0

—

Temporomandibular joint disorders, including avohilmo

1.06

0.07

1.4

2.2

—

Disorders of eyelid, lacrimal system and orbit

0.89

0.07

2.2

2.0

—

Acute sinusitis

0.86

0.06

1.9

2.0

—

Complications of medical and surgical care

1.12

0.06

1.8

2.1

—

Diseases of the skin and subcutaneous tissue

0.93

0.06

1.9

2.1

—

Viral infections characterized by skin and mucous membrane lesions

128

1.07

0.04

1.9

2.0

—

Conjunctivitis

125

0.93

0.04

1.9

2.1

—

Artrosis, including avohilmo

0.92

0.04

1.8

2.0

—

Other dorsopathies, not elsewhere classified

110

1.05

0.03

2.3

2.0

—

Diseases of middle ear and mastoid

105

0.93

0.03

1.9

2.0

—

Acute appendicitis

114

1.07

0.02

2.3

1.9

—

Certain infectious and parasitic diseases

1.07

0.02

1.9

2.1

—

Cardiac arrhythmias

1.08

0.02

1.5

2.2

—

Other pulmonary diagnosis

1.06

0.02

2.0

—

Tonsillectomy and adenotomy

109

0.96

0.01

1.9

2.0

—

Triptan medication for migraine, min. 3 purchases

0.95

0.00

2.1

—

Injuries to the shoulder and upper arm

100

0.97

0.00

1.9

2.1

—

Appendicitis, broad definition

118

1.00

0.00

2.3

1.9

—

Hernia

1.04

0.00

2.0

1.9

—

Abdominal and pelvic pain

0.98

0.00

2.0

2.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.97

0.00

1.7

2.0

—

Suppurative and unspecified otitis media

1.02

0.00

2.2

2.0

—

Diseases of appendix

118

0.99

0.00

2.3

1.9

—

Diseases of the respiratory system

1.04

0.00

1.9

2.2

—

Chronic diseases of tonsils and adenoids

108

0.99

0.00

2.0

—

Infections with a predominantly sexual mode of transmission

101

1.01

0.00

1.6

2.1

—

Excluding asthma or asthma-COPD overlap

0.99

0.00

1.8

2.0

—

Acute appendicitis, no complications

106

1.03

0.00

2.5

1.9

—

Persons with potential health hazards related to communicable diseases

1.02

0.00

1.8

2.1

—

Asthma, including avohilmo

125

0.99

0.00

2.1

2.0

—

Dorsopathies

111

1.01

0.00

2.2

2.0

—

Symptoms and signs involving the digestive system and abdomen

0.98

0.00

2.0

2.1

—

Congenital malformations, deformations and chromosomal abnormalities

121

1.02

0.00

1.5

2.1

—

Secondary hypertension

0.00

0.0

1.8

—

Failed attempted abortion

0.00

0.0

1.8

—

Adrenocortical insufficiency

0.00

0.0

1.8

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

0.00

0.0

1.8

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

0.0

2.0

—

Exposure to other specified electric current

0.00

0.0

1.7

—

Hypoplasia of dental enamel , including avohilmo

0.00

0.0

1.8

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

0.0

2.0

—

Other and specified injuries of hip and thigh

0.00

0.0

1.8

—

Injury of muscle and tendon at hip and thigh level

0.00

0.0

1.9

—

Oral leukoplakia, including avohilmo

0.00

0.0

1.8

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.0

2.2

—

Sequelae of other external causes

0.00

0.0

1.9

—

Dystonia

0.00

0.0

1.9

—

Certain zoonotic bacterial diseases

0.00

0.0

1.7

—

Other blood glucose lowering drugs, excl. Insulins

0.00

0.0

1.6

—

Right bundle-branch block

0.00

0.0

1.8

—

Other salmonella infections

0.00

0.0

2.0

—

Total colectomy operation

0.00

0.0

1.6

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.7

—

0.00

0.0

1.7

—

Erectile dysfunction

0.00

0.0

2.2

—

Other specified/unspecified deforming dorsopathies

0.00

0.0

1.6

—

Disorders of calcium metabolism

0.00

0.0

2.1

—

Use of interferon beta-1a

0.00

0.0

1.8

—

Disorders of speech understanding and production

0.00

0.0

1.7

—

Iliotibial band syndrome

0.00

0.0

2.0

—

Burn and corrosion of wrist and hand

0.00

0.0

1.6

—

Emphysema

0.00

0.0

2.2

—

Total colectomy

0.00

0.0

1.6

—

Other disorders of Eustachian tube

0.00

0.0

1.5

—

Malignant melanoma of skin, including Hilmo

0.00

0.0

2.0

—

Malignant neoplasm of colon, including Hilmo

0.00

0.0

1.8

—

Polycystic kidney disease

0.00

0.0

1.7

—

Idiopathic gout

0.00

0.0

2.1

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

0.0

1.8

—

Struck by thrown, projected or falling objec

0.00

0.0

2.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.8

—

Scleritis

0.00

0.0

1.8

—

Malignant neoplasm of urinary organs

0.00

0.0

2.2

—

Diseases of peritoneum

0.00

0.0

1.9

—

Other and unspecified follicular disorders

0.00

0.0

1.9

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.0

1.9

—

Impacted cerumen

0.00

0.0

1.9

—

Sicca syndrome [Sjögren]

0.00

0.0

1.7

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

1.8

—

Effects of other external causes

0.00

0.0

2.0

—

Other respiratory diseases principally affecting the interstitium

0.00

0.0

1.9

—

6-mercaptopurine

0.00

0.0

1.6

—

Syphilis

0.00

0.0

1.9

—

Other and unspecified mononeuropathies of lower limb

0.00

0.0

1.7

—

Syphilis

0.00

0.0

1.9

—

Achalasia of cardia

0.00

0.0

1.8

—

Other diseases of spinal cord

0.00

0.0

1.7

—

Papillary adenocarcinoma of thyroid gland

0.00

0.0

1.8

—

Other and unspecified psoriasis

0.00

0.0

1.9

—

Other articular cartilage disorders

0.00

0.0

2.0

—

Crohn's disease of large intestine

0.00

0.0

1.8

—

Hypertrophic scar

0.00

0.0

2.2

—

Varicella [chickenpox]

0.00

0.0

2.0

—

Bacterial meningitis

0.00

0.0

1.6

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.6

—

Causalgia

0.00

0.0

1.7

—

Algoneurodystrophy

0.00

0.0

1.6

—

Autoimmune thyroiditis

0.00

0.0

1.6

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

0.0

2.0

—

Nontoxic single thyroid nodule

0.00

0.0

1.8

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.6

—

Other renal tubulo-interstitial diseases

0.00

0.0

2.0

—

Cyst of kidney

0.00

0.0

1.9

—

Unspecified nephritic syndrome

0.00

0.0

1.8

—

Non-allergic asthma

0.00

0.0

2.0

—

Benign neoplasm of eye and adnexa

0.00

0.0

1.9

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.0

1.8

—

Atypical facial pain

0.00

0.0

1.9

—

Other juvenile arthritis

0.00

0.0

1.8

—

ILD, hospital admissions 1, main diag only

0.00

0.0

1.9

—

Excessive, frequent and irregular menstruation

0.93

0.00

1.6

2.1

—

Other, unspecified and serous retinal detachments

0.00

0.0

2.2

—

Other specified/unspecified dorsopathies

0.00

0.0

1.9

—

Infections of breast associated with childbirth

0.00

0.0

1.9

—

Malignant neoplasm of prostate

0.00

0.0

2.2

—

Other disorders of white blood cells

0.00

0.0

1.9

—

Pyogenic granuloma

0.00

0.0

1.8

—

Enteropathic arthropathies

0.00

0.0

1.5

—

Poisoning by medicine, drug-induced

0.00

0.0

1.8

—

Idiopathic urticaria

0.00

0.0

1.6

—

Infection of intervertebral disc (pyogenic)

0.00

-0.00

0.0

1.8

—

Other bullous disorders

0.00

-0.00

0.0

1.6

—

Other disorders of male genital organs

0.00

-0.00

0.0

2.2

—

Inflammatory disorders of breast

0.00

-0.00

0.0

2.1

—

Myeloproliferative diseases

0.00

-0.00

0.0

1.9

—

Vasculitis limited to skin, not elsewhere classified

0.00

-0.00

0.0

1.8

—

Cleft palate

0.00

-0.00

0.0

1.8

—

Cleft lip, lip and palate or palate

0.00

-0.00

0.0

1.8

—

Other specified/unspecified disorders of bone/cartilage

0.00

-0.00

0.0

2.0

—

Other bursitis of knee

0.00

-0.00

0.0

1.7

—

Bicipital tendinitis

0.00

-0.00

0.0

2.0

—

Ingrowing nail

0.00

-0.00

0.0

1.9

—

Other diseases caused by chlamydiae

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

0.00

-0.00

0.0

2.2

—

Other and unspecified nail disorders

0.00

-0.00

0.0

1.7

—

Hypertrichosis

0.00

-0.00

0.0

1.6

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.8

—

Asthma mixed form (mode), excluding more controls

0.00

-0.00

0.0

1.8

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.5

—

Campylobacter enteritis

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.9

—

Other and unspecified local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

2.1

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

2.1

—

Molar incisor enamel hypoplasia

0.00

-0.00

0.0

1.8

—

Other diseases of appendix

0.00

-0.00

0.0

1.8

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

1.6

—

Noninflammatory disorders of female genital tract

0.96

-0.00

2.2

2.1

—

Congenital malformations of breast

0.00

-0.00

0.0

1.6

—

Alopecia areata

0.00

-0.00

0.0

1.8

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

0.00

-0.00

0.0

1.8

—

Deep bite that required surgery

0.00

-0.00

0.0

1.7

—

Ulcer of oesophagus

0.00

-0.00

0.0

2.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Stomach

0.00

-0.00

0.0

1.9

—

Scissor bite

0.00

-0.00

0.0

1.7

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.00

-0.00

0.0

1.6

—

Tuberculosis, IBD comorbidity

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Short bones of upper limb

0.00

-0.00

0.0

1.7

—

Cytomegalovirus infection, IBD co-morbidity

0.00

-0.00

0.0

1.8

—

Portal vein thrombosis

0.00

-0.00

0.0

1.8

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.7

—

Dermatophytosis

0.00

-0.00

0.0

1.9

—

Gastric ulcer

0.00

-0.00

0.0

1.9

—

Noise effects on inner ear

0.00

-0.00

0.0

2.2

—

Other other unspecified disorders of the circulatory system

0.00

-0.00

0.0

1.6

—

Myocardial infarction, unclassifiable

0.00

-0.00

0.0

2.2

—

Vertical strabismus

0.00

-0.00

0.0

1.6

—

Other vitreous opacities

0.00

-0.00

0.0

1.6

—

Peripheral retinal degeneration

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Long bones of lower limb

0.00

-0.00

0.0

2.0

—

Disorders of eyelid in diseases classified elsewhere

0.00

-0.00

0.0

1.6

—

Interstitial lung disease endpoints

0.00

-0.00

0.0

1.9

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

2.0

—

Conductive and sensorineural hearing loss

0.92

-0.00

2.0

1.8

—

Intestinal malabsorption

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

2.0

—

Calcific aortic valvular stenosis

0.00

-0.00

0.0

1.9

—

Other infective otitis externa

0.00

-0.00

0.0

1.9

—

Operations 2 for CAVS

0.00

-0.00

0.0

1.9

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

2.2

—

Endocarditis

0.00

-0.00

0.0

1.6

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

-0.00

0.0

1.9

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

-0.00

0.0

2.0

—

Other specified disorders of external ear

0.00

-0.00

0.0

1.8

—

Chorioretinal inflammation

0.00

-0.00

0.0

1.7

—

Iridocyclitis in diseases classified elsewhere

0.00

-0.00

0.0

1.8

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.7

—

Other encephalitis

0.00

-0.00

0.0

1.7

—

Other acute disseminated demyelination

0.00

-0.00

0.0

1.7

—

Use of teriflunomide

0.00

-0.00

0.0

1.8

—

Bronchiectasis

0.00

-0.00

0.0

1.6

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.7

—

Pyothorax

0.00

-0.00

0.0

2.2

—

Testicular dysfunction

0.00

-0.00

0.0

2.2

—

Other pleural conditions

0.00

-0.00

0.0

2.1

—

Other diseases of gallbladder

0.00

-0.00

0.0

1.6

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.8

—

Alzheimer disease, including avohilmo

0.00

-0.00

0.0

1.6

—

Other diseases of pancreas

0.00

-0.00

0.0

1.9

—

Chronic pancreatitis

0.00

-0.00

0.0

1.9

—

Other specified and unspecified retinal disorders

0.00

-0.00

0.0

1.8

—

conjunctival haemorrhage

0.00

-0.00

0.0

2.0

—

Anomalies of pupillary function

0.00

-0.00

0.0

2.0

—

Other conjunctival vascular disorders and cysts

0.00

-0.00

0.0

1.7

—

Erythema nodosum

0.00

-0.00

0.0

1.6

—

Testicular hypofunction

0.00

-0.00

0.0

2.2

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.5

—

Paraplegia, diplegia of upper limbs

0.00

-0.00

0.0

1.7

—

Urethritis and urethral syndrome

0.00

-0.00

0.0

1.7

—

Juvenile rheumatoid arthirtis

0.00

-0.00

0.0

1.5

—

Benign neoplasm of other and unspecified sites

0.00

-0.00

0.0

1.7

—

Graves ophthalmopathy, strict

0.00

-0.00

0.0

1.8

—

Other disorders of adrenal gland

0.00

-0.00

0.0

1.7

—

Secondary uncertain malignant neoplasm

0.00

-0.00

0.0

1.9

—

Chronic Coagulation defects

0.00

-0.00

0.0

1.7

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

2.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

2.0

—

Other and unspecified disorders of white blood cells

0.00

-0.00

0.0

1.6

—

Hypopituitarism

0.00

-0.00

0.0

2.0

—

Tuberculosis

0.00

-0.00

0.0

1.8

—

Immunodeficiency with predominantly antibody defects

0.00

-0.00

0.0

1.6

—

Monoarthritis, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Immunodeficiencies

0.00

-0.00

0.0

1.8

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.9

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

1.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Benign neoplasm: Tongue

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.6

—

Discitis, unspecified

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Small intestine

0.00

-0.00

0.0

1.8

—

Hypoparathyroidism

0.00

-0.00

0.0

1.7

—

Melanocytic naevi of scalp and neck

0.00

-0.00

0.0

1.7

—

Other facial nerve disorders

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.6

—

Hyperaldosteronism

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Kidney

0.00

-0.00

0.0

1.8

—

Other and unspecified diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.8

—

Degenerative macular diseases

0.00

-0.00

0.0

2.0

—

Stenosis and insufficiency of lacrimal passages

0.00

-0.00

0.0

1.6

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.9

—

Benign neoplasm: Larynx

0.00

-0.00

0.0

2.2

—

Follicular lymphoma, hilmo

0.00

-0.00

0.0

1.6

—

Meralgia paraesthetica

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.8

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Anus and anal canal

0.00

-0.00

0.0

1.8

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.7

—

Retinal vascular occlusion

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Liver/bile ducts

0.00

-0.00

0.0

1.7

—

Infections with a predominantly sexual mode of transmission

0.90

-0.00

1.7

2.0

—

ILD, hospital admissions

0.00

-0.00

0.0

1.9

—

Cardiac arrest

0.00

-0.00

0.0

1.8

—

Malignant melanoma of skin

0.00

-0.00

0.0

2.0

—

Other and unspecified mononeuropathies, also in other diseases

0.00

-0.00

0.0

1.7

—

Guillain-Barre syndrome

0.00

-0.00

0.0

1.8

—

Pericarditis

0.00

-0.00

0.0

1.7

—

Acute alcohol intoxication ICD-9

0.00

-0.00

0.0

2.2

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.7

—

Coronary artery bypass grafting

0.00

-0.00

0.0

2.2

—

Cholelithiasis

0.97

-0.00

1.4

2.2

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.7

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

-0.00

0.0

1.8

—

Other diseases of intestine

0.00

-0.00

0.0

2.0

—

Acute epiglottitis

0.00

-0.00

0.0

1.8

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.9

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

2.0

—

Varicose veins of other sites

0.00

-0.00

0.0

2.2

—

Abnormal findings on examination of urine, without diagnosis

0.00

-0.00

0.0

1.6

—

Other arrhythmias

1.01

-0.00

1.5

2.1

—

Pneumothorax

0.00

-0.00

0.0

2.1

—

Encephalitis

0.00

-0.00

0.0

1.7

—

Vascular disorders of the intestines

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Adrenal gland

0.00

-0.00

0.0

1.9

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

2.0

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.6

—

Viral meningitis

0.00

-0.00

0.0

1.6

—

Asthma mixed form (mode)

0.00

-0.00

0.0

1.8

—

Amiodarone users

0.00

-0.00

0.0

2.2

—

Artificial opening status

0.00

-0.00

0.0

1.7

—

Use of anticholinesterases

0.00

-0.00

0.0

1.9

—

Other embolism and thrombosis

0.00

-0.00

0.0

2.3

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

1.9

—

Viral conjunctivitis

0.00

-0.00

0.0

1.8

—

Other overlap syndromes

0.00

-0.00

0.0

1.8

—

Other specific arthropathies, wide

0.00

-0.00

0.0

1.8

—

Gonococcal infection

0.00

-0.00

0.0

1.7

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

1.8

—

Mandibular retrognathia AND surgery (BSSO)

0.00

-0.00

0.0

1.6

—

Arterial embolism and thrombosis

0.00

-0.00

0.0

1.8

—

Gonococcal infection

0.00

-0.00

0.0

1.7

—

Early syphilis

0.00

-0.00

0.0

1.8

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

2.2

—

Migraine without aura, drug-induced

0.00

-0.00

0.0

1.8

—

Dermatitis due to ingested food

0.00

-0.00

0.0

1.8

—

Early syphilis

0.00

-0.00

0.0

1.8

—

Inguinal hernia

0.95

-0.00

2.0

1.7

—

Cholecystectomy

0.99

-0.00

1.4

2.2

—

Venous complications and haemorrhoids in pregnancy

0.00

-0.00

0.0

1.7

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

2.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.9

—

Viral encephalitis, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.8

—

Spasmodic torticollis

0.00

-0.00

0.0

1.7

—

Diseases caused by chlamydiae

0.00

-0.00

0.0

1.7

—

Varicella [chickenpox]

0.00

-0.00

0.0

2.0

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

2.2

—

Other/unspecified cytomegaloviral diseases

0.00

-0.00

0.0

1.8

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.7

—

Eosinophilia

0.00

-0.00

0.0

1.8

—

Other interstitial pulmonary diseases

0.00

-0.00

0.0

1.9

—

Certain zoonotic bacterial diseases

0.00

-0.00

0.0

1.8

—

Other diseases caused by chlamydiae

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Liver

0.00

-0.00

0.0

1.7

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.9

—

Respiratory tuberculosis

0.00

-0.00

0.0

1.8

—

Other and unspecified mononeuropathies of upper limb

0.00

-0.00

0.0

2.0

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

2.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.6

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

2.2

—

Cholesteatoma of middle ear

0.00

-0.00

0.0

2.2

—

Glomerular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.9

—

Other and unspecified mental retardation

0.00

-0.00

0.0

1.8

—

Protozoal diseases

0.00

-0.00

0.0

1.6

—

Other diseases of pericardium

0.00

-0.00

0.0

1.7

—

Lesion of lateral popliteal nerve

0.00

-0.00

0.0

2.0

—

Other necrotizing vasculopathies (FG)

0.00

-0.00

0.0

2.0

—

Systemic lupus erythematosus

0.00

-0.00

0.0

1.7

—

Synovial hypertrophy, not elsewhere classified

0.00

-0.00

0.0

1.8

—

Valvular operations

0.00

-0.00

0.0

1.7

—

Biological medicines for asthma

0.00

-0.00

0.0

1.7

—

Lesion of radial nerve

0.00

-0.00

0.0

1.7

—

Other specified and unspecified disorders of eye and adnexa

0.00

-0.00

0.0

1.6

—

Malignant neoplasm of kidney, except renal pelvis

0.00

-0.00

0.0

2.2

—

Donors of organs and tissues

0.00

-0.00

0.0

1.8

—

Interstitial lung disease

0.00

-0.00

0.0

1.9

—

Asthma and opportunity respiratory infection

0.00

-0.00

0.0

1.5

—

Secondary polycythaemia

0.00

-0.00

0.0

1.8

—

Unknown and unspecified causes of morbidity

0.00

-0.00

0.0

2.7

—

Benign neoplasm: Skin, unspecified

0.00

-0.00

0.0

1.6

—

Hypertrophic disorders of skin

0.00

-0.00

0.0

2.2

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

1.5

—

Allergic purpura

0.00

-0.00

0.0

1.7

—

Rheumatic fever incl heart disease

0.00

-0.00

0.0

1.8

—

Guttate psoriasis

0.00

-0.00

0.0

1.8

—

Cauda equina syndrome

0.00

-0.00

0.0

1.8

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

-0.00

0.0

1.7

—

Blood alcohol or alcohol intoxication level

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Skin of trunk

0.00

-0.00

0.0

1.6

—

Bullous disorders

0.00

-0.00

0.0

1.9

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

2.0

—

Melanocytic naevi of other and unspecified parts of face

0.00

-0.00

0.0

1.7

—

Contact with machinery

0.00

-0.00

0.0

2.0

—

Other and unspecified vascular occlusions

0.00

-0.00

0.0

1.8

—

Chondromalacia

0.00

-0.00

0.0

1.9

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

1.8

—

SLE, strict definition

0.00

-0.00

0.0

1.7

—

Systemic lupus erythematosus, unspecified

0.00

-0.00

0.0

1.7

—

Hodgkin lymphoma, hilmo

0.00

-0.00

0.0

1.8

—

Other disorders of bone density and structure

0.00

-0.00

0.0

2.0

—

Symptoms and signs involving the skin and subcutaneous tissue

0.94

-0.00

1.6

2.1

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.9

—

Benign neoplasm: Skin of lower limb, including hip

0.00

-0.00

0.0

1.7

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

-0.00

0.0

2.0

—

Cholelithiasis, broad definition with cholecystitis

0.93

-0.00

1.4

2.2

—

Abnormal spermatozoa

0.00

-0.00

0.0

2.2

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

2.2

—

Special screening examination for neoplasms

0.00

-0.00

0.0

1.6

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

2.0

—

Procedures for purposes other than remedying health state

0.00

-0.00

0.0

1.7

—

Other surgical follow-up care

0.00

-0.00

0.0

2.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

ARIPiprazole [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS